Article
Combined effects of adeno-associated virus vector and a herpes simplex virus mutant as neoplastic therapy.
Journal of surgical oncology - 1 Jul 2000
Kasuya H, Mizuno M, Yoshida J, Nishiyama Y, Nomoto S, Nakao A
Abstract excerpt
BACKGROUND AND OBJECTIVES: Although surgical therapy for pancreatic cancer has not been successful, new gene therapies, such as adeno-associated virus (AAV) vectors hold promise for treating cancer. However, expression of AAV vectors alone is insufficient for adequate effects in vivo for cancer therapy. We describe a novel therapy using the combined herpes simplex virus-ICP6 deletion mutant (ICP6delta) and AAV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
